The company’s global analysis from thousands of studies and sites indicates dramatic shifts in enrollment across several countries since the pandemic began.
Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.
A report by Science 37 examines key considerations for patient safety and business continuity in the clinical trial industry in light of the ongoing coronavirus pandemic.
